Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery
ConditionCardiovascular Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMedtronic Cardiac Surgery
About this trial
The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.
Eligibility criteria
Qualifiers
Subject or legally authorized representative provides written data release and/or informed consent per institution and/or geographical requirements prior to discharge from participating registry hospital.
Subject will undergo or underwent a procedure in which an eligible Medtronic CS product is/was used.
Disqualifiers
Currently participating in an interventional drug or device study which may induce confounding factor(s) to the results from this Registry
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov